Zobrazeno 1 - 10
of 128
pro vyhledávání: '"D, Pontvert"'
Autor:
M, Gauthé, O, Belissant, A, Girard, J, Zhang Yin, J, Ohnona, A-S, Cottereau, V, Nataf, S, Balogova, D, Pontvert, T, Lebret, B, Guillonneau, O, Cussenot, J-N, Talbot
Publikováno v:
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 27(8-9)
Since April 201, we have introduced PET/CT using a ligand of prostate-specific membrane antigen labeled with gallium-68 (PSMA-11). We aimed to evaluate its positivity rate and impact in patients presenting biochemical recurrence of prostate cancer wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dc411cdc2cfbfdda2ba110f89c398cde
https://pubmed.ncbi.nlm.nih.gov/28576423
https://pubmed.ncbi.nlm.nih.gov/28576423
Publikováno v:
Annales d'Endocrinologie. 68:337-348
Pituitary adenomas represent approximately 12% of intracranial tumors. They are defined as tumors that are functional or nonfunctional and invasive or noninvasive. Therapeutic strategies rely on surgery, medical treatment, and radiotherapy depending
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac96ecbe5641c8802509f8efaebf8e07
https://doi.org/10.1016/j.ando.2007.03.012
https://doi.org/10.1016/j.ando.2007.03.012
Autor:
Pierre Schlienger, CH Haie, Jean-Marc Cosset, D. Pontvert, J. L. Habrand, S. Helfre, C. Lenir-Cohen-Solal, A. Mazal, L. Schwartz
Publikováno v:
Radiation and Environmental Biophysics. 34:41-44
Proton therapy offers potentially considerable advantages in the management of slow-growing, poorly resectable or non-resectable tumors resistant to x-rays and located close to critical radiosensitive anatomical structures, such as the brain stem of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c587a38d933eefc24487f120dcbfa61f
https://doi.org/10.1007/bf01210544
https://doi.org/10.1007/bf01210544
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 12(6-7)
With an experience of more than 20 years for the pionneers (and more than 10 years in France), permanent implant brachytherapy using Iodin 125 seeds is now recognized as a valuable alternative therapy for localized low-risk prostate cancer patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14f4fbc960e99e8c3edb77db383941e5
https://pubmed.ncbi.nlm.nih.gov/18829365
https://pubmed.ncbi.nlm.nih.gov/18829365
Autor:
D, Pontvert, G, Gaboriaud, T, Flam, N, Jourdan-Da Silva, N, Thiounn, H, Mammar, P, Beuzeboc, B, Debré
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 12(2)
To describe therapeutic modalities for localized prostate cancer treated by conformal radiation to 76Gy with or without androgen ablation. To evaluate the preliminary results in terms of survival, biological control and toxicity.Between January 1998
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3310fda1a7529580044cb4d5e53eb8e4
https://pubmed.ncbi.nlm.nih.gov/18248831
https://pubmed.ncbi.nlm.nih.gov/18248831
Autor:
J-M, Cosset, T, Flam, N, Thiounn, J-C, Rosenwald, D, Pontvert, M, Timbert, S, Solignac, L, Chauveinc
Publikováno v:
Bulletin du cancer. 93(8)
Whereas it has been proposed almost one century ago, brachytherapy for prostate cancer has only recently emerged, especially thanks to endorectal echography, allowing to visualize seed implantation, to the development of seeds for permanent delivery
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4cccd07d1c206d5414d9973a704fb101
https://pubmed.ncbi.nlm.nih.gov/16935780
https://pubmed.ncbi.nlm.nih.gov/16935780
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 8(6)
Intensity modulated radiation therapy (IMRT) is based on a methodology called inverse planning. Starting from dosimetric objectives, constraints of optimization are fixed and given to the inverse planning system, which in turn calculates the modulate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ed3184b0b5d0a8069f2716aebc9381e
https://pubmed.ncbi.nlm.nih.gov/15619378
https://pubmed.ncbi.nlm.nih.gov/15619378
Autor:
J L, Habrand, C, Haie-Meder, A, Rey, H, Mammar, D, Pontvert, G, Gaboriaud, D, Couanet, C, Lenir, D, Valinta, R, Ferrand, G, Boisserie, A, Beaudré, K, Kerody, A, Mazal, N, Dupouy, M, Bonomi, J J, Mazeron
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 3(6)
From October 1993 through July 1998, 48 assessable adult patients with non-resectable aggressive intracranial tumors were treated by a combination of high dose photon + proton therapy at the Centre de Protonthérapie d'Orsay.Grade 1 and 4 gliomas wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aea233aa5692a69c02ccdf00c3c14edf
https://pubmed.ncbi.nlm.nih.gov/10630161
https://pubmed.ncbi.nlm.nih.gov/10630161
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 3(5)
Recent progress in radiotherapeutic management of localized prostate cancer is reviewed. Clinical aspects--including dose-effect beyond 70 Gy, relative role of conformal radiation therapy techniques and of early hormonal treatment--are discussed as w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::11175dcc118dd88259c7e936920a0d06
https://pubmed.ncbi.nlm.nih.gov/10572509
https://pubmed.ncbi.nlm.nih.gov/10572509
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 3(5)
'Conformal radiotherapy' is the name fixed by usage and given to a new form of radiotherapy resulting from the technological improvements observed during, the last ten years. While this terminology is now widely used, no precise definition can be fou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be29e3ecfd2e9f6b4e4cf4442eb17ded
https://pubmed.ncbi.nlm.nih.gov/10572507
https://pubmed.ncbi.nlm.nih.gov/10572507